Modern Laboratory Techniques for Antiphospholipid Syndrome Testing

Posted May 15th, 2017 No comments »

John Rodrigo, MD, Postdoctoral Scholar
Fabian Lara, MD, Postdoctoral Scholar
Saba Ali, MD, Resident Pathologist
Denis Dwyre, MD, Director of Hematopathology
Grace Monis, MD, Special Coagulation
Sarah Barnhard, MD, Associate Director of Transfusion
Scott Bainbridge, CLS, Special Chemistry/Toxicology Supervisor
Nam Tran, PhD, Director of Clinical Chemistry and SARC

Background: Antiphospholipid syndrome (APS) is an autoimmune disorder Read Full Post »






Enhanced Detection of Syphilis Infection: Implementation of a Reverse Testing Algorithm

Posted April 15th, 2017 No comments »

Scott Bainbridge, CLS, Special Chemistry/Toxicology Supervisor
Jennifer Brown, MD, Division of Infectious Diseases
Nam K. Tran, PhD, MS, FACB, Clinical Chemistry and POCT

Background: Syphilis is caused by the spirochete bacteria Treponema pallidum. Read Full Post »






Enhanced Detection of Autoimmune Disease: Implementation of a Fully Automated, Random Access Multiplexing Platform for Antinuclear Antibody (ANA) Screening

Posted March 15th, 2017 No comments »

Scott Bainbridge, CLS, Special Chemistry/Toxicology Supervisor
Nam K. Tran, PhD, MS, FACB, Director of Clinical Chemistry and POCT

Background: Autoimmune diseases are often characterized as immune responses directed toward self. Read Full Post »






Point of Care Testing for Blood Conservation Strategies: Finding the Right Tools Matters

Posted February 15th, 2017 No comments »

Andrew D Jones, MD, MA, PGY2, Pathology and Laboratory Medicine
Fabian Lara, MD, Postdoctoral Scholar, Pathology and Laboratory Medicine
Nam K Tran, PhD, MS, FACB, Director of Clinical Chemistry and POCT

Background: Patient Blood Management programs have, over the last several years, Read Full Post »






SAFETY AND COMPLIANCE MONITORING OF PATIENTS RECEIVING CHRONIC OPIOID THERAPY

Posted February 2nd, 2017 No comments »

BACKGROUND
Patients receiving chronic opioid therapy (COT) should be randomly tested for elicit drug use and/or compliance with prescribed medications.1 Recent guidelines recommend drug testing must be implemented from initiation and followed by subsequent adherence monitoring to decrease prescription drug abuse or illicit drug use when patients are in chronic pain management therapy. Urine drug testing serves as the primary specimen type for COT monitoring. Read Full Post »






INAPPROPRIATE LUBRICATING GELS CAN INCREASE UNSATISFACTORY RATE OF THE PAP TEST

Posted February 2nd, 2017 No comments »

Alicia Calderon Bhambra DO, Cytopathology Fellow
Donald York CT (ASCP), Cytopathology Supervisor
Alaa Afify MD, Director of Cytopathology

Background: The Hologic ThinPrep¬© Pap Test is the most utilized methodology for cervical cytology sample collection. Read Full Post »






PROCALCITONIN FOR ANTIMICROBIAL STEWARDSHIP AND THE MANAGEMENT OF SEPSIS

Posted February 2nd, 2017 No comments »

Background: Procalcitonin (PCT) is a peptide precursor to calcitonin that is associated with the inflammatory response to bacterial infection. Studies have shown PCT levels increasing following bacterial infection (6 hours) and aids in the risk assessment of critically ill patients on their first day of intensive care unit admission for progression to severe sepsis and septic shock.1-3 Other PCT applications include recognition of infection in febrile infants4 and antimicrobial stewardship3. Read Full Post »